Skip to main content
. Author manuscript; available in PMC: 2023 Jul 20.
Published in final edited form as: Head Neck. 2020 Oct 23;43(2):613–621. doi: 10.1002/hed.26510

TABLE 2.

Clinical characteristics of patients who did and did not receive induction chemotherapy

No. (%)
Characteristic No induction chemotherapy Induction chemotherapy P
Total 358 204
Tumor (T classification) <.001
 TO or Txa 0 (0.0) 2 (1.0)
 T1 60 (16.8) 19 (9.3)
 T2 146 (40.8) 44 (21.6)
 T3 83 (23.2) 64 (31.4)
 T4 69 (19.3) 75 (36.8)
Dental extraction <.001
 No 254 (70.9) 101 (49.5)
 Yes 104 (29.1) 103 (50.5)
Alcohol use .188
 No 138 (38.5) 91 (44.6)
 Yes 220 (61.5) 113 (55.4)
Smokingb .070
 No 193 (53.9) 93 (45.6)
 Yes 165 (46.1) 111 (54.4)
Hypomagnesemia during treatment course <.001
 No 224 (62.6) 64 (31.4)
 Yes 134 (37.4) 140 (68.6)
Hypomagnesemia grading <.001
 No hypomagnesemia 224 (62.6) 64 (31.4)
 Grade 1 123 (34.4) 127 (62.3)
 Grade 2 and more 11 (3.1) 13 (6.4)
Frequency of hypomagnesemia (IQR) 0 (0, 1) 2 (0, 6) <.001
Median radiation dose (IQR) 70 Gy (66–70 Gy) 70 Gy (70–70 Gy) .032
Surgeryc .198
 No 309 (86.3) 167 (81.9)
 Yes 49 (13.7) 37 (18.1)
ORN .632
 No 295 (82.4) 164 (80.4)
 Yes 63 (17.6) 40 (19.6)
Cisplatin cumulative dose (mg) 415 (348, 498) 498 (360, 756) <.001
Carboplatin cumulative dose (mg) 1129 (762, 1498) 1943 (1479, 3003) <.001
Use of cetuximab <.001
 No 357 (99.7) 127 (62.3)
 Yes 1 (0.3) 77 (37.7)
Use of PPI .028
 No 302 (84.4) 156 (76.5)
 Yes 56 (15.6) 48 (23.5)
Use of diuretics .027
 No 353 (98.6) 194 (95.1)
 Yes 5 (1.4) 10 (4.9)

Note: The values marked in bold italics indicate statistical significance (P < .05).

Abbreviations: IQR, interquartile range; ORN, osteoradionecrosis.

a

Tx refers no primary tumor.

b

Nonsmoker or smoked less than 5 pack-year.

c

Head and neck surgery before radiation excluding biopsy and tonsillectomy.